Medivis Receives FDA 510(k) Clearance for Spine Navigation and Announces Commercial Launch in the United States
Medivis Inc., a pioneer in surgical intelligence, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Spine Navigation platform. This milestone marks a significant advancement in surgical technology, utilizing AR and AI to empower surgeons with holographic navigation across open and minimally invasive spine procedures. Alongside the FDA clearance, Medivis is announcing the commercial launch of Spine Navigation, making it available to hospitals and ambulatory surgical centers nationwide. Medivis‘ Spine Navigation platform is applicable across neurosurgery and orthopedic surgery. Its key strengths include: Spine Navigation is the latest addition to the company’s portfolio of AI-powered surgical solutions, which are designed to transform the operating room and enhance surgical precision across a range of specialties.
